Jayakumar Arumugam, Kang Ya'an, Frederick Mitchell J, Pak Stephen C, Henderson Ying, Holton Paula R, Mitsudo Kenji, Silverman Gary A, EL-Naggar Adel K, Brömme Dieter, Clayman Gary L
Department of Head and Neck Surgery, M.D. Anderson Cancer Center, The University of Texas, 1515 Holcombe Blvd., Houston, TX 77030-4095, USA.
Arch Biochem Biophys. 2003 Jan 15;409(2):367-74. doi: 10.1016/s0003-9861(02)00635-5.
Headpin (SERPINB13) is a novel member of the serine proteinase inhibitor (Serpin) gene family that was originally cloned from a keratinocyte cDNA library. Western blot analysis using a headpin-specific antiserum recognized a protein with the predicted M(r) of 44kDa in lysates derived from a transformed keratinocyte cell line known to express headpin mRNA. Similarity of the reactive-site loop (RSL) domain of headpin, notably at the P1-P1(') residues, with other serpins that inhibit cysteine and serine proteinases suggests that headpin may inhibit similar proteinases. This study demonstrates that recombinant headpin indeed inhibits cathepsins K and L, but not chymotrypsin, elastase, trypsin, subtilisin A, urokinase-type plasminogen activator, plasmin, or thrombin. The second-order rate constants (k(a)) for the inhibitory reactions of rHeadpin with cathepsins K and L were 5.1+/-0.6x10(4) and 4.1+/-0.8x10(4)M(-1)s(-1), respectively. Headpin formed SDS-stable complexes with cathepsins K and L, a characteristic property of inhibitory serpins. Interactions of the RSL domain of headpin with cathepsins K and L were indicated by cleavage of headpin near the predicted P1-P1(') residues by these proteinases. These results demonstrate that the serpin headpin possesses specificity for inhibiting lysosomal cysteine proteinases.
主钉蛋白(丝氨酸蛋白酶抑制剂B13,SERPINB13)是丝氨酸蛋白酶抑制剂(Serpin)基因家族的一个新成员,最初是从角质形成细胞cDNA文库中克隆出来的。使用主钉蛋白特异性抗血清进行的蛋白质印迹分析,在源自已知表达主钉蛋白mRNA的转化角质形成细胞系的裂解物中,识别出一种预测分子量为44kDa的蛋白质。主钉蛋白反应位点环(RSL)结构域,特别是在P1 - P1'残基处,与其他抑制半胱氨酸和丝氨酸蛋白酶的丝氨酸蛋白酶抑制剂的相似性表明,主钉蛋白可能抑制类似的蛋白酶。本研究表明,重组主钉蛋白确实抑制组织蛋白酶K和L,但不抑制胰凝乳蛋白酶、弹性蛋白酶、胰蛋白酶、枯草杆菌蛋白酶A、尿激酶型纤溶酶原激活剂、纤溶酶或凝血酶。重组主钉蛋白与组织蛋白酶K和L的抑制反应的二级速率常数(k(a))分别为5.1±0.6×10(4)和4.1±0.8×10(4)M(-1)s(-1)。主钉蛋白与组织蛋白酶K和L形成了SDS稳定的复合物,这是抑制性丝氨酸蛋白酶抑制剂的一个特征特性。这些蛋白酶在预测的P1 - P1'残基附近切割主钉蛋白,表明主钉蛋白的RSL结构域与组织蛋白酶K和L之间存在相互作用。这些结果表明,丝氨酸蛋白酶抑制剂主钉蛋白具有抑制溶酶体半胱氨酸蛋白酶的特异性。